Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden
Identifieur interne : 00AF33 ( Main/Exploration ); précédent : 00AF32; suivant : 00AF34Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden
Auteurs : Howard Feldman [Canada] ; Serge Gauthier [Canada] ; Jane Hecker [Australie] ; Bruno Vellas [France] ; Birol Emir ; Vera Mastey ; Ponni Subbiah [États-Unis] ; Ponni The Donepezil Msad Study Investigators Group [Canada]Source :
- Journal of the American Geriatrics Society [ 0002-8614 ] ; 2003-06.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Neurologie, Personne âgée.
English descriptors
- KwdEn :
- Acetylcholinesterase, Activity, Adls, Aggregate time, Alzheimer, Alzheimer disease, Anticholinesterase agent, Badls, Baseline, Baseline scores, Baseline time, Basic adls, Caregiver, Caregiver burden, Caregiver demographics, Caregiver diary, Caregiver stress, Caregiver stress scale, Caregiver time, Caregiving, Caregiving competence, Clinic visit, Clinical trial, Current study, Daily living, Dementia, Disability assessment, Donepezil, Donepezil group, Donepezil treatment, Effective performance, Elderly, Enzyme inhibitor, Feldman, Functional abilities, Functional ability, Future studies, Health, Iadl, Iadl activities, Iadls, Improvement, Instrumental activities, Jag, June, Last observation, Least squares, Locf, Maintenance, Medication, Neurology, Patient, Personal gain, Piperidine derivatives, Placebo, Placebo group, Placebotreated patients, Pleasurable activities, Psms, Psms activities, Randomized, Same amount, Senile dementia, Severe, Severe disease, Significant differences, Slower decline, Social behavior, Study medication, Total scores, Treatment difference, Treatment differences, Treatment groups.
- Teeft :
- Adls, Aggregate time, Alzheimer, Alzheimer disease, Badls, Baseline, Baseline scores, Baseline time, Basic adls, Caregiver, Caregiver burden, Caregiver demographics, Caregiver diary, Caregiver stress, Caregiver stress scale, Caregiver time, Caregiving, Caregiving competence, Clinic visit, Clinical trial, Current study, Dementia, Disability assessment, Donepezil, Donepezil group, Donepezil treatment, Effective performance, Feldman, Functional abilities, Functional ability, Future studies, Iadl, Iadl activities, Iadls, Instrumental activities, Jag, June, Last observation, Least squares, Locf, Medication, Neurology, Personal gain, Placebo, Placebo group, Placebotreated patients, Pleasurable activities, Psms, Psms activities, Randomized, Same amount, Severe disease, Significant differences, Slower decline, Social behavior, Study medication, Total scores, Treatment difference, Treatment differences, Treatment groups.
Abstract
OBJECTIVES: This study investigated the efficacy of donepezil treatment on activities of daily living (ADLs) and social functioning in patients with moderate to severe Alzheimer's disease (AD) and the possible benefits of this treatment on caregiving time and stress levels.
Url:
DOI: 10.1046/j.1365-2389.2003.51260.x
Affiliations:
- Australie, Canada, France, États-Unis
- Midi-Pyrénées, Occitanie (région administrative), État de New York
- Toulouse
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000779
- to stream Istex, to step Curation: 000779
- to stream Istex, to step Checkpoint: 001B39
- to stream Main, to step Merge: 00BC72
- to stream PascalFrancis, to step Corpus: 005202
- to stream PascalFrancis, to step Curation: 000F24
- to stream PascalFrancis, to step Checkpoint: 004D38
- to stream Main, to step Merge: 00BD23
- to stream Main, to step Curation: 00AF33
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden</title>
<author><name sortKey="Feldman, Howard" sort="Feldman, Howard" uniqKey="Feldman H" first="Howard" last="Feldman">Howard Feldman</name>
</author>
<author><name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name>
</author>
<author><name sortKey="Hecker, Jane" sort="Hecker, Jane" uniqKey="Hecker J" first="Jane" last="Hecker">Jane Hecker</name>
</author>
<author><name sortKey="Vellas, Bruno" sort="Vellas, Bruno" uniqKey="Vellas B" first="Bruno" last="Vellas">Bruno Vellas</name>
</author>
<author><name sortKey="Emir, Birol" sort="Emir, Birol" uniqKey="Emir B" first="Birol" last="Emir">Birol Emir</name>
</author>
<author><name sortKey="Mastey, Vera" sort="Mastey, Vera" uniqKey="Mastey V" first="Vera" last="Mastey">Vera Mastey</name>
</author>
<author><name sortKey="Subbiah, Ponni" sort="Subbiah, Ponni" uniqKey="Subbiah P" first="Ponni" last="Subbiah">Ponni Subbiah</name>
</author>
<author><name sortKey="The Donepezil Msad Study Investigators Group, Ponni" sort="The Donepezil Msad Study Investigators Group, Ponni" uniqKey="The Donepezil Msad Study Investigators Group P" first="Ponni" last="The Donepezil Msad Study Investigators Group">Ponni The Donepezil Msad Study Investigators Group</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2827A5140BA119F2C24B0095739E9BBB9CFF51F6</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1046/j.1365-2389.2003.51260.x</idno>
<idno type="url">https://api.istex.fr/document/2827A5140BA119F2C24B0095739E9BBB9CFF51F6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000779</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000779</idno>
<idno type="wicri:Area/Istex/Curation">000779</idno>
<idno type="wicri:Area/Istex/Checkpoint">001B39</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001B39</idno>
<idno type="wicri:doubleKey">0002-8614:2003:Feldman H:efficacy:of:donepezil</idno>
<idno type="wicri:Area/Main/Merge">00BC72</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:03-0440479</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">005202</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000F24</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">004D38</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004D38</idno>
<idno type="wicri:doubleKey">0002-8614:2003:Feldman H:efficacy:of:donepezil</idno>
<idno type="wicri:Area/Main/Merge">00BD23</idno>
<idno type="wicri:Area/Main/Curation">00AF33</idno>
<idno type="wicri:Area/Main/Exploration">00AF33</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden</title>
<author><name sortKey="Feldman, Howard" sort="Feldman, Howard" uniqKey="Feldman H" first="Howard" last="Feldman">Howard Feldman</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Division of Neurology, UBC Hospital, Clinic for Alzheimer's Disease and Related Disorders, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Alzheimer Disease Research Unit, McGill Center for Studies in Aging,Verdun, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hecker, Jane" sort="Hecker, Jane" uniqKey="Hecker J" first="Jane" last="Hecker">Jane Hecker</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>Department of Rehabilitation and Aged Care, Repatriation General Hospital, Daw Park, SA</wicri:regionArea>
<wicri:noRegion>SA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vellas, Bruno" sort="Vellas, Bruno" uniqKey="Vellas B" first="Bruno" last="Vellas">Bruno Vellas</name>
<affiliation wicri:level="3"><country xml:lang="fr" wicri:curation="lc">France</country>
<wicri:regionArea>ToulouseUniversity Alzheimer's Center, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Emir, Birol" sort="Emir, Birol" uniqKey="Emir B" first="Birol" last="Emir">Birol Emir</name>
<affiliation><wicri:noCountry code="no comma">Clinical Data Operations and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Mastey, Vera" sort="Mastey, Vera" uniqKey="Mastey V" first="Vera" last="Mastey">Vera Mastey</name>
<affiliation><wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Subbiah, Ponni" sort="Subbiah, Ponni" uniqKey="Subbiah P" first="Ponni" last="Subbiah">Ponni Subbiah</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Pfizer Pharmaceuticals Group, Pfizer, Inc.,New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="The Donepezil Msad Study Investigators Group, Ponni" sort="The Donepezil Msad Study Investigators Group, Ponni" uniqKey="The Donepezil Msad Study Investigators Group P" first="Ponni" last="The Donepezil Msad Study Investigators Group">Ponni The Donepezil Msad Study Investigators Group</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Division of Neurology, UBC Hospital, Clinic for Alzheimer's Disease and Related Disorders, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of the American Geriatrics Society</title>
<title level="j" type="alt">JOURNAL OF AMERICAN GERIATRICS SOCIETY</title>
<idno type="ISSN">0002-8614</idno>
<idno type="eISSN">1532-5415</idno>
<imprint><biblScope unit="vol">51</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="737">737</biblScope>
<biblScope unit="page" to="744">744</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Blackwell Science Inc</publisher>
<pubPlace>Boston, MA, USA</pubPlace>
<date type="published" when="2003-06">2003-06</date>
</imprint>
<idno type="ISSN">0002-8614</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0002-8614</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acetylcholinesterase</term>
<term>Activity</term>
<term>Adls</term>
<term>Aggregate time</term>
<term>Alzheimer</term>
<term>Alzheimer disease</term>
<term>Anticholinesterase agent</term>
<term>Badls</term>
<term>Baseline</term>
<term>Baseline scores</term>
<term>Baseline time</term>
<term>Basic adls</term>
<term>Caregiver</term>
<term>Caregiver burden</term>
<term>Caregiver demographics</term>
<term>Caregiver diary</term>
<term>Caregiver stress</term>
<term>Caregiver stress scale</term>
<term>Caregiver time</term>
<term>Caregiving</term>
<term>Caregiving competence</term>
<term>Clinic visit</term>
<term>Clinical trial</term>
<term>Current study</term>
<term>Daily living</term>
<term>Dementia</term>
<term>Disability assessment</term>
<term>Donepezil</term>
<term>Donepezil group</term>
<term>Donepezil treatment</term>
<term>Effective performance</term>
<term>Elderly</term>
<term>Enzyme inhibitor</term>
<term>Feldman</term>
<term>Functional abilities</term>
<term>Functional ability</term>
<term>Future studies</term>
<term>Health</term>
<term>Iadl</term>
<term>Iadl activities</term>
<term>Iadls</term>
<term>Improvement</term>
<term>Instrumental activities</term>
<term>Jag</term>
<term>June</term>
<term>Last observation</term>
<term>Least squares</term>
<term>Locf</term>
<term>Maintenance</term>
<term>Medication</term>
<term>Neurology</term>
<term>Patient</term>
<term>Personal gain</term>
<term>Piperidine derivatives</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Placebotreated patients</term>
<term>Pleasurable activities</term>
<term>Psms</term>
<term>Psms activities</term>
<term>Randomized</term>
<term>Same amount</term>
<term>Senile dementia</term>
<term>Severe</term>
<term>Severe disease</term>
<term>Significant differences</term>
<term>Slower decline</term>
<term>Social behavior</term>
<term>Study medication</term>
<term>Total scores</term>
<term>Treatment difference</term>
<term>Treatment differences</term>
<term>Treatment groups</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Acetylcholinesterase</term>
<term>Activité</term>
<term>Aidant</term>
<term>Amélioration</term>
<term>Anticholinestérasique</term>
<term>Donépézil</term>
<term>Démence Alzheimer</term>
<term>Démence sénile</term>
<term>Grave</term>
<term>Inhibiteur enzyme</term>
<term>Maintenance</term>
<term>Malade</term>
<term>Personne âgée</term>
<term>Pipéridine dérivé</term>
<term>Santé</term>
<term>Vie quotidienne</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Adls</term>
<term>Aggregate time</term>
<term>Alzheimer</term>
<term>Alzheimer disease</term>
<term>Badls</term>
<term>Baseline</term>
<term>Baseline scores</term>
<term>Baseline time</term>
<term>Basic adls</term>
<term>Caregiver</term>
<term>Caregiver burden</term>
<term>Caregiver demographics</term>
<term>Caregiver diary</term>
<term>Caregiver stress</term>
<term>Caregiver stress scale</term>
<term>Caregiver time</term>
<term>Caregiving</term>
<term>Caregiving competence</term>
<term>Clinic visit</term>
<term>Clinical trial</term>
<term>Current study</term>
<term>Dementia</term>
<term>Disability assessment</term>
<term>Donepezil</term>
<term>Donepezil group</term>
<term>Donepezil treatment</term>
<term>Effective performance</term>
<term>Feldman</term>
<term>Functional abilities</term>
<term>Functional ability</term>
<term>Future studies</term>
<term>Iadl</term>
<term>Iadl activities</term>
<term>Iadls</term>
<term>Instrumental activities</term>
<term>Jag</term>
<term>June</term>
<term>Last observation</term>
<term>Least squares</term>
<term>Locf</term>
<term>Medication</term>
<term>Neurology</term>
<term>Personal gain</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Placebotreated patients</term>
<term>Pleasurable activities</term>
<term>Psms</term>
<term>Psms activities</term>
<term>Randomized</term>
<term>Same amount</term>
<term>Severe disease</term>
<term>Significant differences</term>
<term>Slower decline</term>
<term>Social behavior</term>
<term>Study medication</term>
<term>Total scores</term>
<term>Treatment difference</term>
<term>Treatment differences</term>
<term>Treatment groups</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Neurologie</term>
<term>Personne âgée</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">OBJECTIVES: This study investigated the efficacy of donepezil treatment on activities of daily living (ADLs) and social functioning in patients with moderate to severe Alzheimer's disease (AD) and the possible benefits of this treatment on caregiving time and stress levels.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
<li>État de New York</li>
</region>
<settlement><li>Toulouse</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Emir, Birol" sort="Emir, Birol" uniqKey="Emir B" first="Birol" last="Emir">Birol Emir</name>
<name sortKey="Mastey, Vera" sort="Mastey, Vera" uniqKey="Mastey V" first="Vera" last="Mastey">Vera Mastey</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Feldman, Howard" sort="Feldman, Howard" uniqKey="Feldman H" first="Howard" last="Feldman">Howard Feldman</name>
</noRegion>
<name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name>
<name sortKey="The Donepezil Msad Study Investigators Group, Ponni" sort="The Donepezil Msad Study Investigators Group, Ponni" uniqKey="The Donepezil Msad Study Investigators Group P" first="Ponni" last="The Donepezil Msad Study Investigators Group">Ponni The Donepezil Msad Study Investigators Group</name>
</country>
<country name="Australie"><noRegion><name sortKey="Hecker, Jane" sort="Hecker, Jane" uniqKey="Hecker J" first="Jane" last="Hecker">Jane Hecker</name>
</noRegion>
</country>
<country name="France"><region name="Occitanie (région administrative)"><name sortKey="Vellas, Bruno" sort="Vellas, Bruno" uniqKey="Vellas B" first="Bruno" last="Vellas">Bruno Vellas</name>
</region>
</country>
<country name="États-Unis"><region name="État de New York"><name sortKey="Subbiah, Ponni" sort="Subbiah, Ponni" uniqKey="Subbiah P" first="Ponni" last="Subbiah">Ponni Subbiah</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00AF33 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00AF33 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:2827A5140BA119F2C24B0095739E9BBB9CFF51F6 |texte= Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden }}
This area was generated with Dilib version V0.6.33. |